Biocept Inc (BIOC):企業財務及び戦略的SWOT分析

【英語タイトル】Biocept Inc (BIOC) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(GDME5968FSA)・商品コード:GDME5968FSA
・発行会社(調査会社):GlobalData
・発行日:2017年1月13日
・ページ数:25
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Biocept Inc (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company caters to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept Inc Key Recent Developments

Jan 10, 2017: Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas
Nov 09, 2016: Biocept Reports 2016 Third Quarter Financial Results
Oct 27, 2016: Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications
Sep 23, 2016: Biocept’s Proprietary Liquid Biopsy Platform to be Featured at Two Upcoming Molecular Diagnostics Conferences
Sep 09, 2016: Biocept to Collaborate with Renowned Clinical Investigator Dr. Shilpa Gupta to Study the Utility of Liquid Biopsy Testing in Bladder and Prostate Cancers

This comprehensive SWOT profile of Biocept Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biocept Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Biocept Inc – Key Information
Biocept Inc – Overview
Biocept Inc – Key Employees
Biocept Inc – Key Employee Biographies
Biocept Inc – Key Operational Heads
Biocept Inc – Major Products and Services
Biocept Inc – History
Biocept Inc – Company Statement
Biocept Inc – Locations And Subsidiaries
Biocept Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biocept Inc – Business Description
Biocept Inc – Corporate Strategy
Biocept Inc – SWOT Analysis
SWOT Analysis – Overview
Biocept Inc – Strengths
Biocept Inc – Weaknesses
Biocept Inc – Opportunities
Biocept Inc – Threats
Biocept Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Biocept Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biocept Inc, Key Information
Biocept Inc, Key Ratios
Biocept Inc, Share Data
Biocept Inc, Major Products and Services
Biocept Inc, History
Biocept Inc, Key Employees
Biocept Inc, Key Employee Biographies
Biocept Inc, Key Operational Heads
Biocept Inc, Other Locations
Biocept Inc, Subsidiaries
Biocept Inc, Key Manufacturing facilities
Biocept Inc, Key Competitors
Biocept Inc, SWOT Analysis
Biocept Inc, Ratios based on current share price
Biocept Inc, Annual Ratios
Biocept Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biocept Inc, Performance Chart
Biocept Inc, Ratio Charts

★調査レポート[Biocept Inc (BIOC):企業財務及び戦略的SWOT分析] (コード:GDME5968FSA)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biocept Inc (BIOC):企業財務及び戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆